Vilin Bio Med Limited is engaged in the domestic business of manufacturing pharmaceutical products, and the manufacturing unit. The company sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who provide the channel for sales to customers.
The IPO comprises of a total issue 4,000,000 shares (aggregating up to ₹12.00 Cr)
The company intends to utilize the proceeds from the net issue for the following objects: 1. Augmenting additional working capital requirements, and 2. General Corporate Purposes
The allotment date of Vilin Bio Med IPO is set for 26th June, 2023.